CliniMACS CD34^-selected cells to support multiple cycles of high-dose therapy

By Prince HM   Wall D   Rischin D   Toner GC   Seymour JF   Blakey D   Haylock D   Simmons P   Wolf M   Januszewicz EH   Westerman D   Richardson G   Scarlett J   Briggs P  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 147-155

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products

By Braakman E.   Schuurhuis Gj   Preijers Fwmb   Voermans C.   Theunissen K.   van Riet I.   Fibbe We   Slaper-Cortenbach I.  

Cytotherapy, Vol. 10, Iss. 1, 2007-12 ,pp. : 83-89

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD133 immunomagnetic separation: effectiveness of the method for CD133⁺ isolation from umbilical cord blood

By Pelagiadis Iordanis   Relakis Konstantinos   Kalmanti Lida   Dimitriou Helen  

Cytotherapy, Vol. 14, Iss. 6, 2012-07 ,pp. : 701-706

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Large Scale Purification of Human Blood CD34⁺ Cells Using a Nylon-fiber Syringe System and Immunomagnetic Microspheres

By Koizumi K   Sawada K   Sato N   Yamaguchi M   Nishio M   Tarumi T   Takano H   Fukada Y   Ieko M   Yasukouchi T   Sekiguchi S   Koike T  

Cytotherapy, Vol. 1, Iss. 4, 1999-01 ,pp. : 319-327

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Enhanced generation of megakaryocytes from umbilical cord blood-derived CD34⁺ cells expanded in the presence of two nutraceuticals, docosahexanoic acid and arachidonic acid, as supplements to the cytokine-containing medium

By Siddiqui Nikhat Firdaus A.   Shabrani Namrata C.   Kale Vaijayanti P.   Limaye Lalita S.  

Cytotherapy, Vol. 13, Iss. 1, 2011-01 ,pp. : 114-128

Ashgate Publishing Ltd

Access to resources Recommend Favorite